{"id":"flufenamic-acid","rwe":[{"pmid":"41842337","year":"2026","title":"Repurposing flufenamic acid as a putative PmrB-directed adjuvant to restore colistin activity in Klebsiella pneumoniae.","finding":"","journal":"Microbiology spectrum","studyType":"Clinical Study"},{"pmid":"41787983","year":"2026","title":"Efficacy of shortwave radiofrequency-assisted delivery of Quhong Zhiyang ointment in the treatment of facial seborrheic dermatitis: a retrospective study of 72 patients.","finding":"","journal":"Cutaneous and ocular toxicology","studyType":"Clinical Study"},{"pmid":"41588428","year":"2026","title":"Inflammation-responsive biomimetic hybrid nanovesicles reverse stem cell senescence by up-regulating SIRT1 to treat periodontitis.","finding":"","journal":"Journal of nanobiotechnology","studyType":"Clinical Study"},{"pmid":"41542630","year":"2026","title":"Degradation of the TEAD•YAP/TAZ Transcription Factor Complex by Heterobifunctional Small Molecules that Bind to the TEAD Allosteric Lipid Pocket.","finding":"","journal":"bioRxiv : the preprint server for biology","studyType":"Clinical Study"},{"pmid":"41500005","year":"2026","title":"Flufenamic acid fosters bacterial clearance by inhibiting Staphylococcus aureus AgrA and NLRP3 inflammasome of phagocytes.","finding":"","journal":"Microbiological research","studyType":"Clinical Study"}],"tags":[{"label":"flufenamic acid","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Nicotinate phosphoribosyltransferase","category":"target"},{"label":"NAPRT","category":"gene"},{"label":"KCNT2","category":"gene"},{"label":"TTR","category":"gene"},{"label":"M01AG03","category":"atc"},{"label":"Active","category":"status"},{"label":"Pain","category":"indication"},{"label":"Anti-Inflammatory Agents","category":"pharmacology"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=FLUFENAMIC ACID","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:12:38.944735+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:12:44.707690+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FLUFENAMIC ACID","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:12:45.019566+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL23588/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:12:46.302381+00:00"}},"allNames":"fluphenamic acid","offLabel":[],"synonyms":["flufenamic acid","fluphenamic acid"],"timeline":[{"date":"1963-01-01","type":"positive","source":"DrugCentral","milestone":"YEAR INTRODUCED approval"}],"approvals":[{"date":"1963-01-01","orphan":false,"company":"","regulator":"YEAR INTRODUCED"}],"brandName":"Fluphenamic Acid","ecosystem":[{"indication":"Pain","otherDrugs":[{"name":"acetylsalicylic acid","slug":"acetylsalicylic-acid","company":"Endo Pharms"},{"name":"bromfenac","slug":"bromfenac","company":"Bausch And Lomb Inc"},{"name":"butorphanol","slug":"butorphanol","company":""},{"name":"caffeine","slug":"caffeine","company":"Novartis"}],"globalPrevalence":1500000000}],"mechanism":{"target":"Nicotinate phosphoribosyltransferase","targets":[{"gene":"NAPRT","source":"DrugCentral","target":"Nicotinate phosphoribosyltransferase","protein":"Nicotinate phosphoribosyltransferase"},{"gene":"KCNT2","source":"DrugCentral","target":"Potassium channel subfamily T member 2","protein":"Potassium channel subfamily T member 2"},{"gene":"TTR","source":"DrugCentral","target":"Transthyretin","protein":"Transthyretin"},{"gene":"PTGS2","source":"DrugCentral","target":"Prostaglandin G/H synthase 2","protein":"Prostaglandin G/H synthase 2"},{"gene":"TAS2R14","source":"DrugCentral","target":"Taste receptor type 2 member 14","protein":"Taste receptor type 2 member 14"},{"gene":"AKR1B10","source":"DrugCentral","target":"Aldo-keto reductase family 1 member B10","protein":"Aldo-keto reductase family 1 member B10"},{"gene":"AKR1C3","source":"DrugCentral","target":"Aldo-keto reductase family 1 member C3","protein":"Aldo-keto reductase family 1 member C3"},{"gene":"AKR1C2","source":"DrugCentral","target":"Aldo-keto reductase family 1 member C2","protein":"Aldo-keto reductase family 1 member C2"},{"gene":"MPO","source":"DrugCentral","target":"Myeloperoxidase","protein":"Myeloperoxidase"},{"gene":"TRPM4","source":"DrugCentral","target":"Transient receptor potential cation channel subfamily M member 4","protein":"Transient receptor potential cation channel subfamily M member 4"}],"modality":"Small Molecule","drugClass":"flufenamic acid","explanation":"","oneSentence":"","technicalDetail":"Fluphenamic Acid inhibits the enzyme Nicotinate phosphoribosyltransferase, which is involved in the synthesis of prostaglandins from arachidonic acid. This inhibition leads to a decrease in prostaglandin production, resulting in reduced pain and inflammation."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1193","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=FLUFENAMIC%20ACID","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FLUFENAMIC ACID","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:30:26.943302","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:12:47.922742+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"mefenamic acid","drugSlug":"mefenamic-acid","fdaApproval":"1967-03-28","genericCount":5,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"meclofenamic acid","drugSlug":"meclofenamic-acid","fdaApproval":"1980-06-25","relationship":"same-class"}],"genericName":"flufenamic acid","indications":{"approved":[{"name":"Pain","source":"DrugCentral","snomedId":22253000,"regulator":"FDA","usPrevalence":51600000,"globalPrevalence":1500000000,"prevalenceMethod":"curated","prevalenceSource":"CDC, 2023"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"mefenamic-acid","brandName":"mefenamic acid","genericName":"mefenamic acid","approvalYear":"1967","relationship":"same-class"},{"drugId":"meclofenamic-acid","brandName":"meclofenamic acid","genericName":"meclofenamic acid","approvalYear":"1980","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT04253132","phase":"PHASE1,PHASE2","title":"Evaluation of Tolfenamic Acid in Individuals With PSP at 12-Weeks","status":"UNKNOWN","sponsor":"NeuroTau, Inc.","startDate":"2021-01-01","conditions":["Progressive Supranuclear Palsy"],"enrollment":24,"completionDate":"2022-12-31"},{"nctId":"NCT03238612","phase":"PHASE2","title":"Flufenamic Acid for Hospitalised Influenza Infection","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2018-01-08","conditions":["Influenza A"],"enrollment":200,"completionDate":"2020-10-31"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000166663","NDDF":"004195","UNII":"60GCX7Y6BH","CHEBI":"CHEBI:42638","INN_ID":"1495","RXNORM":"4453","UMLSCUI":"C0016282","chemblId":"CHEMBL23588","ChEMBL_ID":"CHEMBL23588","KEGG_DRUG":"D01581","DRUGBANK_ID":"DB02266","PDB_CHEM_ID":" FLF","PUBCHEM_CID":"3371","SNOMEDCT_US":"1156232002","IUPHAR_LIGAND_ID":"2447","MESH_DESCRIPTOR_UI":"D005439"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":1136,"therapeuticAreas":["Pain"],"atcClassification":{"source":"DrugCentral","atcCode":"M01AG03","allCodes":["M01AG03"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar 17","pmid":"41842337","title":"Repurposing flufenamic acid as a putative PmrB-directed adjuvant to restore colistin activity in Klebsiella pneumoniae.","journal":"Microbiology spectrum"},{"date":"2026 Mar 6","pmid":"41787983","title":"Efficacy of shortwave radiofrequency-assisted delivery of Quhong Zhiyang ointment in the treatment of facial seborrheic dermatitis: a retrospective study of 72 patients.","journal":"Cutaneous and ocular toxicology"},{"date":"2026 Jan 26","pmid":"41588428","title":"Inflammation-responsive biomimetic hybrid nanovesicles reverse stem cell senescence by up-regulating SIRT1 to treat periodontitis.","journal":"Journal of nanobiotechnology"},{"date":"2026 Jan 11","pmid":"41542630","title":"Degradation of the TEAD•YAP/TAZ Transcription Factor Complex by Heterobifunctional Small Molecules that Bind to the TEAD Allosteric Lipid Pocket.","journal":"bioRxiv : the preprint server for biology"},{"date":"2026 Apr","pmid":"41500005","title":"Flufenamic acid fosters bacterial clearance by inhibiting Staphylococcus aureus AgrA and NLRP3 inflammasome of phagocytes.","journal":"Microbiological research"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"OTHER","regulator":"YEAR INTRODUCED","status":"approved","approval_date":"1963-01-01T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:12:47.922742+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}